Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Chronic Heart Failure

Free Subscription 16.02.2026 1 Am Heart J 3 Am J Cardiol 2 Clin Cardiol 3 Eur Heart J 3 Heart 1 Int J Cardiol 4 J Am Coll Cardiol 3 J Card Fail 2 J Cardiol 1 Lancet 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. BOLLI R, Tang XL, Hare JM, Mitrani RD, et al
   Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.
   Am Heart J. 2026;294:107328.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. SAWANO M, Xin X, Wu I, Wang Y, et al
   Heart Failure Outcomes Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
   Am J Cardiol. 2026 Feb 11:S0002-9149(26)00061.
   PubMed         Abstract available
   
   
3. SHARMA S, Giri G, Desai A, Ruiz J, et al
   Managing Obesity in Heart Failure Patients: Current Evidence and Strategies.
   Am J Cardiol. 2026 Feb 10:S0002-9149(26)00057.
   PubMed         Abstract available
   
   
4. SEN T, Demir M, Batak CN, Yildirimturk O, et al
   Clinical Approaches in Heart Failure: Perspectives of Cardiologists in Turkiye (HF-PERSPECTIVE).
   Am J Cardiol. 2026 Feb 8:S0002-9149(26)00053.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

5. GOLOMBECK D, Khandokar R, Fishbein J, Provenzale A, et al
   Assessment of Point of Care Lung Ultrasound in the Ambulatory Heart Failure Setting.
   Clin Cardiol. 2026;49:e70244.
   PubMed         Abstract available
   
   
6. BLOOD AJ, Unlu O, Ostrominski JW, Hassan S, et al
   Rationale and Design of the Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure.
   Clin Cardiol. 2026;49:e70222.
   PubMed         Abstract available
   
   

   
   Eur Heart J

7. DUNCKER D, Marijon E, Bauersachs J
   Sudden cardiac death risk in the early vulnerable phase of heart failure: clarifying the SCD-PROTECT findings.
   Eur Heart J. 2026 Feb 13:ehag054. doi: 10.1093.
   PubMed        
   
   
8. CREA F
   Focus on trials: atrial fibrillation, heart failure with reduced ejection fraction, acute coronary syndrome, ischaemic stroke, and renovascular hypertension.
   Eur Heart J. 2026;47:649-654.
   PubMed        
   
   
9. ROSSELLO X, Dominguez-Rodriguez A, Latini R, Sanchez PL, et al
   Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial.
   Eur Heart J. 2025 Aug 30:ehaf673. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Heart

10. AZAR M, Apostolo A, Salvioni E, Galotta A, et al
    Cardiopulmonary exercise test criteria for heart transplantation referral of patients with ambulatory heart failure in the current era.
    Heart. 2026 Feb 11:heartjnl-2025-327208. doi: 10.1136/heartjnl-2025-327208.
    PubMed         Abstract available
    
    
11. TAN E, Meei-Wah C, Teo YH, Tan LF, et al
    Survival benefit of guideline-directed medical therapy in older patients with heart failure: a systematic review and meta-analysis.
    Heart. 2026 Feb 11:heartjnl-2025-326305. doi: 10.1136/heartjnl-2025-326305.
    PubMed         Abstract available
    
    
12. LUO E, Cuthbert JJ, Kazmi S, Rigby AS, et al
    Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure.
    Heart. 2026 Feb 9:heartjnl-2025-327093. doi: 10.1136/heartjnl-2025-327093.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

13. JURA M, Przybylski R, Niewinski P, Sokolski M, et al
    Central venous pressure, rather than cardiac output, is associated with peripheral chemoreceptor sensitivity in heart failure patients with left ventricular assist device.
    Int J Cardiol. 2026;450:134228.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

14. BUTLER J, Khan MS, Ferreira JP, Girerd N, et al
    Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways.
    J Am Coll Cardiol. 2026 Feb 11:S0735-1097(25)10560.
    PubMed         Abstract available
    
    
15. CANNATA A, Chew K, Bromage DI, McDonagh TA, et al
    Heart Failure With Preserved Ejection Fraction: Clinical Judgment Beyond Diastolic Algorithms.
    J Am Coll Cardiol. 2026 Jan 30:S0735-1097(25)10603.
    PubMed        
    
    
16. SPENCER-BONILLA G, Fan J, Cheng P, Varshney A, et al
    Delayed Diagnosis of Transthyretin Amyloid Cardiomyopathy in the Veterans Health Administration.
    J Am Coll Cardiol. 2026;87:533-545.
    PubMed         Abstract available
    
    
17. KITTLESON MM, Ambardekar AV, Cheng RK, Griffin JM, et al
    Transthyretin Cardiac Amyloidosis Evaluation and Management: 2025 ACC Concise Clinical Guidance.
    J Am Coll Cardiol. 2026;87:549-565.
    PubMed         Abstract available
    
    

    
    J Card Fail

18. MARGULIES KB
    Advancing the Future of Heart Failure Care Through the HFSA Devices Initiative.
    J Card Fail. 2026;32:553-554.
    PubMed        
    
    
19. MOURA-FERREIRA S, Crisci G, Verwerft J
    Pocket Lung Ultrasound in Ambulatory Heart Failure With Preserved Ejection Fraction: Pulmonary Congestion as a Point-Of-Care Phenotype.
    J Card Fail. 2026 Feb 7:S1071-9164(26)00038.
    PubMed        
    
    
20. CIKES M, Planinc I, Brugts JJ, Claggett B, et al
    Rationale, design, and baseline characteristics of the multicENter, randomized, open-label, parallel group, study to evaluate the use of sacubitril/valsartan in HeartMate 3 left ventricular assist device recipients (ENVAD-HF).
    J Card Fail. 2026;32:406-418.
    PubMed         Abstract available
    
    

    
    J Cardiol

21. SAITOH M, Ida Y, Iwata K, Kato M, et al
    Prognostic impact of noncardiac comorbidities on hospitalization-associated disability and 1-year outcomes in older patients with heart failure - Findings from the J-proof HF.
    J Cardiol. 2026 Feb 6:S0914-5087(26)00030-4. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available
    
    
22. KOW CS, Wong YC, Zaihan AF, Thiruchelvam K, et al
    Beyond avoidance: The unaddressed analgesic gap in patients with heart failure contraindicated for NSAIDs and COX-2 inhibitors.
    J Cardiol. 2026 Feb 5:S0914-5087(26)00023-7. doi: 10.1016/j.jjcc.2026.
    PubMed        
    
    

    
    Lancet

23. KELSHIKER MA, Bachtiger P, Petri CF, Nakhare S, et al
    Triple cardiovascular disease detection with an artificial intelligence-enabled stethoscope (TRICORDER) in the UK: a cluster-randomised controlled implementation trial.
    Lancet. 2026 Jan 28:S0140-6736(25)02156-7. doi: 10.1016/S0140-6736(25)02156.
    PubMed         Abstract available
    
    

    
    PLoS One

24. GOLLMER J, Zweiker D, Peikert A, Santner V, et al
    Simultaneous transcatheter edge-to-edge repair (TEER) for severe mitral and tricuspid regurgitation is feasible, safe, and associated with good clinical outcome.
    PLoS One. 2026;21:e0339837.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum